The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 08, 2022
Filed:
Oct. 06, 2020
Applicant:
Levation Pharma Ltd., Beverly Hills, CA (US);
Inventors:
Frank Litvack, Los Angeles, CA (US);
Houman Hemmati, Los Angeles, CA (US);
Assignee:
LEVATION PHARMA LTD., Beverly Hills, CA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 31/4174 (2006.01); A61P 21/00 (2006.01); A61P 27/02 (2006.01); A61Q 19/00 (2006.01); A61K 8/49 (2006.01); A61Q 1/10 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0014 (2013.01); A61K 8/4946 (2013.01); A61K 9/0019 (2013.01); A61K 9/0048 (2013.01); A61K 31/4174 (2013.01); A61P 21/00 (2018.01); A61P 27/02 (2018.01); A61Q 1/10 (2013.01); A61Q 19/00 (2013.01);
Abstract
The disclosure provides cosmetic and therapeutic compositions of alpha-adrenergic agents. Compositions of the disclosure may be used for topical, transdermal or parenteral administration to the eye or eyelid. The compositions of the disclosure may be used cosmetically to improve the appearance of the eye or therapeutically to treat ptosis.